John Canan
CIK 1374366 · Sr.V-P Finc-Global Controller · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.98M
Companies
5
Total Filings
42
Lifetime Open-Market Net
-$1.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEX | Director | 62,076 | $63.80 | $3.96M | $0 | 1 | 2026-02-04 |
| REV Group, Inc. (REVG) Delisted | Director | 2,105 | $63.90 | $134.5K | $80.8K | 12 | 2026-02-02 |
| Grace Therapeutics, Inc. (ACST) Delisted | Director | — | $3.37 | — | $0 | 2 | 2022-09-30 |
| MRK | Sr.V-P Finc-Global Controller | 16,955 | $119.05 | $2.02M | -$1.91M | 23 | 2014-02-26 |
| Merck & Co., Inc. (MRKpB) Delisted | Sr V-P & Controller | 15,168 | — | — | $0 | 4 | 2010-05-11 |
Recent Filings · Page 3 of 5
42 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-07-26 | MRK | Mixed | +6,161 | -$152.3K | EDGAR |
| 2012-05-04 | MRK | Grant (A) | — | $0 | EDGAR |
| 2012-04-26 | MRK | Mixed | +3,675 | -$80.4K | EDGAR |
| 2012-03-01 | MRK | Grant (A) | +4,268 | $163.8K | EDGAR |
| 2011-05-06 | MRK | Grant (A) | — | $0 | EDGAR |
| 2011-03-01 | MRK | Mixed | +3,150 | -$57.9K | EDGAR |
| 2011-02-24 | MRK | Grant (A) | +3,761 | $121.6K | EDGAR |
| 2010-05-11 | Merck & Co., Inc. (MRKpB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-03-04 | Merck & Co., Inc. (MRKpB) Delisted | Mixed | +2,386 | -$50.8K | EDGAR |
| 2010-01-26 | Merck & Co., Inc. (MRKpB) Delisted | Grant (A) | +2,688 | $101.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.